Malladi Drugs Pharmaceuticals Limited | 4CH-021901 | Related Intermediates | Manufacturers & Suppliers

4CH-021901

Chemistry, 5 End Use API, 16 Related Intermediates

Manufacturers/Suppliers

5 Suppliers

5 Suppliers

Also known as: 57280-22-5, 4,4-dimethyl-3,5,8-trioxabic-yclo[5,1,0]octane, Mfcd16621162, 4,4-dimethyl-3,5,8-trioxabicyclo(5.1.0)octane, 4,4-dimethyl-3,5,8-trioxabicyclo-[5.1.0]-octane, Ec 421-750-9

Molecular Formula

C₇H₁₂O₃

Molecular Weight

144.17 g/mol

InChI Key

GEKNCWQQNMEIMS-UHFFFAOYSA-N

1 2D Structure

4CH-021901

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane

2.1.2 InChI

InChI=1S/C7H12O3/c1-7(2)8-3-5-6(10-5)4-9-7/h5-6H,3-4H2,1-2H3

2.1.3 InChI Key

GEKNCWQQNMEIMS-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1(OCC2C(O2)CO1)C

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 57280-22-5

2. 4,4-dimethyl-3,5,8-trioxabic-yclo[5,1,0]octane

3. Mfcd16621162

4. 4,4-dimethyl-3,5,8-trioxabicyclo(5.1.0)octane

5. 4,4-dimethyl-3,5,8-trioxabicyclo-[5.1.0]-octane

6. Ec 421-750-9

7. 4,4-dimethyl-3,5,8-trioxabicyclo[5,1,0]octane

8. Schembl1223255

9. Amy5474

10. Dtxsid10972789

11. Bcp17091

12. Cs1776

13. Akos016007973

14. Sb40516

15. Ac-26559

16. As-19260

17. Sy053244

18. Cs-0043326

19. D5200

20. 4,4-dimethyl-3,5, 8-trioxabicyclo[5.1.0]octane

21. A1-01688

2.3 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₇H₁₂O₃
Molecular Weight	144.17 g/mol
XLogP3	0.2
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	0
Exact Mass	144.078644241 g/mol
Monoisotopic Mass	144.078644241 g/mol
Topological Polar Surface Area	31 Å²
Heavy Atom Count	10
Formal Charge	0
Complexity	130
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Malladi Drugs & Pharmaceuticals Lim...

Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

Contact Supplier

India

Virtual Booth

Digital Content

1,4,7,10-Tetraazacyclododecane- 1,4,7-triacetic acid tr...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

217973-03-0

End Use API

Gadobutrol

About the Company

Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...

Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.